Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Accelerating evidence generation to implementation: Establishment of the Leading Awareness to Action through Implementation of Cardiometabolic Efforts (LATTICE) consortium.

American journal of preventive cardiology·2025

Same author

Role of endothelial CXCR4 in the development of aortic valve stenosis.

Frontiers in cardiovascular medicine·2022

Same author

Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes.

Diabetes care·2019

Same author

Stromal Cell-Derived Factor 1 Plasmid Regenerates Both Smooth and Skeletal Muscle After Anal Sphincter Injury in the Long Term.

Diseases of the colon and rectum·2017

Same author

Regenerating the Anal Sphincter: Cytokines, Stem Cells, or Both?

Diseases of the colon and rectum·2017

Same author

Functional outcome after anal sphincter injury and treatment with mesenchymal stem cells.

Stem cells translational medicine·2014

Search research articles

Related Experiment Video

Updated: May 12, 2026

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

Stem cell treatment for myocardial infarction.

¹Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Desk F25, 9500 Euclid Avenue, Cleveland, OH 44195, USA. pennm@ccf.org

The Journal of Invasive Cardiology

|April 12, 2013

Summary

Autologous cell transplantation and stem cell mobilization show promise for regenerating heart muscle after acute myocardial infarction (AMI). This review explores their potential for treating ischemic cardiomyopathy.

Area of Science:

Regenerative Medicine
Cardiology
Stem Cell Biology

Background:

Acute myocardial infarction (AMI) can lead to ischemic cardiomyopathy, a debilitating condition.
Current treatments for ischemic cardiomyopathy have limitations in promoting myocardial regeneration.
Cellular therapies offer a potential avenue for repairing damaged heart tissue.

Purpose of the Study:

To review the current progress and feasibility of autologous cell transplantation for myocardial regeneration.
To assess the potential of stem cell mobilization as a therapeutic strategy for ischemic cardiomyopathy.
To provide an overview of these regenerative approaches for patients with AMI.

Main Methods:

Literature review of studies on autologous cell transplantation in AMI.

More Related Videos

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Intramyocardial Cell Delivery: Observations in Murine Hearts

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Related Experiment Videos

Last Updated: May 12, 2026

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Intramyocardial Cell Delivery: Observations in Murine Hearts

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Analysis of research on stem cell mobilization techniques and outcomes.

Evaluation of clinical trial data and preclinical findings.

Main Results:

Autologous cell transplantation has demonstrated potential in preclinical and early clinical studies.
Stem cell mobilization strategies are being investigated for their efficacy in enhancing cardiac repair.
Both approaches require further research to establish optimal protocols and long-term safety.

Conclusions:

Autologous cell transplantation and stem cell mobilization are promising, yet still developing, strategies for myocardial regeneration.
Further investigation is crucial to determine the clinical utility of these cell-based therapies for ischemic cardiomyopathy.
These regenerative approaches hold potential for improving outcomes in patients post-AMI.